Position in TGTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,125,171
+$444,826 QoQ
Shares Held
20,480
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#181
of 425 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIT INVESTMENT ASSOCIATES INC holds $12,820,881 across 7 Biotechnology names. TGTX ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
15,900 | $4,240,848 | |
| 2 | VCEL |
Vericel Corp
|
83,185 | $3,700,900 | |
| 3 | TECH |
BIO-TECHNE Corp
|
31,875 | $2,251,968 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
20,480 | $1,125,171 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
28,900 | $757,758 | |
| 6 | SPRY |
ARS Pharmaceuticals, Inc.
|
92,875 | $743,928 | |
| 7 | MREO |
Mereo BioPharma Group plc
|
970 | $308 |
All Filings in TGTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,125,171 | 20,480 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $680,345 | 20,480 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $610,508 | 20,480 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $739,840 | 20,480 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||